论文部分内容阅读
目的分析儿科呼吸系统分暗敷感染患儿的临床治疗效果。方法选取2015年11月至2016年11月来我院治疗反复感染患儿104例,并按照随机原则将患儿分为实验组与对照组。对照组患儿行常规治疗,实验组患儿在常规治疗基础上加用匹多莫德口服液治疗,对两组患儿治疗效果、感染次数进行比较。结果实验组患儿治疗有效率高于对照组患儿,且实验组患儿感染次数低于对照组患儿(P<0.05),具有统计学意义。结论在儿科呼吸系统反复感染患儿治疗中,利用匹多莫德辅助治疗,临床效果显著。
Objective To analyze the clinical effect of pediatric respiratory system subfoveal infection in children. Methods From November 2015 to November 2016, 104 children with recurrent infections were treated in our hospital. According to the random principle, the children were divided into experimental group and control group. Children in the control group were treated routinely. The children in the experimental group were treated with Pidotimod oral solution on the basis of routine treatment. The treatment effect and the frequency of infection in the two groups were compared. Results The effective rate of treatment in experimental group was higher than that of control group, and the frequency of infection in experimental group was lower than that in control group (P <0.05), with statistical significance. Conclusions In the treatment of pediatric patients with recurrent respiratory infections, the use of pidotimod adjuvant therapy, the clinical effect was significant.